Literature DB >> 3397764

Brain metastases with an unknown primary: a clinical perspective.

L Eapen1, M Vachet, G Catton, C Danjoux, R McDermot, B Nair, A Girard, P Genest, D Stewart, L Gerig.   

Abstract

A review of 43 patients with cerebral metastases, an unknown primary, and no other sites of metastases is presented. 27/43 (62.7%) had solitary metastases and 37.2% (16/43) had multiple metastases. Surgical treatment involved complete resection in 30.2%, subtotal resection in 37.2% and biopsy alone or no surgical procedure in the remainder. 39/43 patients underwent whole brain irradiation with the majority receiving 3,000-4,000 rads/10-20 fractions. Overall survival was 52% at six months and 20% at one year, and was significantly better in patients with solitary as opposed to multiple metastases (p less than 0.03). A failure analysis including autopsy data demonstrates that (28/41) 68.3% of patients died of progressive intracranial disease without extracerebral metastases. Implications for treatment strategies are discussed.

Entities:  

Mesh:

Year:  1988        PMID: 3397764     DOI: 10.1007/bf00163538

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  5 in total

1.  Treatment of the patient with adenocarcinoma of unknown origin.

Authors:  C G Moertel; R J Reitemeier; A J Schutt; R G Hahn
Journal:  Cancer       Date:  1972-12       Impact factor: 6.860

2.  The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group.

Authors:  B Borgelt; R Gelber; S Kramer; L W Brady; C H Chang; L W Davis; C A Perez; F R Hendrickson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1980-01       Impact factor: 7.038

3.  Metastatic cancer of unknown origin: nonsquamous cell type.

Authors:  K H Neumann; J S Nystrom
Journal:  Semin Oncol       Date:  1982-12       Impact factor: 4.929

4.  Metastatic cancer of unknown origin: epidermoid and undifferentiated carcinomas.

Authors:  C Silverman; J E Marks
Journal:  Semin Oncol       Date:  1982-12       Impact factor: 4.929

5.  Metastatic and histologic presentations in unknown primary cancer.

Authors:  J S Nystrom; J M Weiner; J Heffelfinger-Juttner; L E Irwin; J R Bateman; R M Wolf
Journal:  Semin Oncol       Date:  1977-03       Impact factor: 4.929

  5 in total
  3 in total

1.  Determination of lung as the primary site of cerebral metastatic adenocarcinomas using monoclonal antibody to thyroid transcription factor-1.

Authors:  R J Bohinski; P A Bejarano; G Balko; R E Warnick; J A Whitsett
Journal:  J Neurooncol       Date:  1998-12       Impact factor: 4.130

2.  Brain metastases in patients with cancer of unknown primary.

Authors:  Susanne Bartelt; Johannes Lutterbach
Journal:  J Neurooncol       Date:  2003-09       Impact factor: 4.130

3.  Single brain metastases from unknown primary malignancies in CT-era.

Authors:  M Salvati; L Cervoni; A Raco
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.